{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:26:00Z","timestamp":1785205560548,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.neuropharm.2024.109931","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T01:40:21Z","timestamp":1712022021000},"page":"109931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring the effect of 6-BIO and sulindac in modulation of Wnt\/\u03b2-catenin signaling pathway in chronic phase of temporal lobe epilepsy"],"prefix":"10.1016","volume":"251","author":[{"given":"Vipasha","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arushi","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parampreet Singh","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5925-7159","authenticated-orcid":false,"given":"Lekha","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.109931_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04557","article-title":"The evolution of the pilocarpine animal model of status epilepticus","volume":"6","author":"Ahmed Juvale","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2024.109931_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.109931_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2007.05.001","article-title":"Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats","volume":"53","author":"Brandt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.109931_bib4","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1523\/JNEUROSCI.5230-04.2005","article-title":"Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death","volume":"25","author":"Cappuccio","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109931_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2138169","article-title":"The treadmill exercise protects against dopaminergic neuron loss and brain oxidative stress in parkinsonian rats","volume":"2017","author":"da Costa","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.109931_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00323","article-title":"Neural activities in multiple rat brain regions in lithium-pilocarpine-induced status epilepticus model","volume":"12","author":"Fan","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109931_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jnen\/61.10.903","article-title":"Differential regulation of cadherins and catenins during axonal reorganization in the adult rat CNS","volume":"61","author":"Fasen","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.109931_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1073858415574728","article-title":"Hippocampal Wnt signaling: memory regulation and hormone interactions","volume":"22","author":"Fortress","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2024.109931_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174469","article-title":"An insight into crosstalk among multiple signaling pathways contributing to epileptogenesis","volume":"910","author":"Gautam","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-1211(01)00272-8","article-title":"Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy","volume":"46","author":"Glien","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2024.109931_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.32607\/20758251-2015-7-2-42-47","article-title":"NeuN as a neuronal nuclear antigen and neuron differentiation marker","volume":"7","author":"Gusel\u2019nikova","year":"2015","journal-title":"Acta Naturae"},{"key":"10.1016\/j.neuropharm.2024.109931_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eplepsyres.2018.07.002","article-title":"Wnt\/\u03b2-catenin signaling as a potential target for novel epilepsy therapies","volume":"146","author":"Hodges","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2024.109931_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/oby.2007.573","article-title":"NIH ImageJ and Slice-O-Matic computed tomography imaging software to quantify soft tissue","volume":"15","author":"Irving","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.neuropharm.2024.109931_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2006.02.016","article-title":"Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"23","author":"Jung","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.109931_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.neuropharm.2024.109931_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbrc.2010.03.163","article-title":"Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model","volume":"395","author":"Lim","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.109931_bib18","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0006-3223(03)00700-5","article-title":"Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis","volume":"54","author":"Madsen","year":"2003","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109931_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2014.06.019","article-title":"Protective mechanism of sulindac in an animal model of ischemic stroke","volume":"1576","author":"Modi","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.109931_bib20","series-title":"StatPearls","article-title":"Mesial temporal lobe epilepsy","author":"Nayak","year":"2023"},{"key":"10.1016\/j.neuropharm.2024.109931_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jep.2008.11.006","article-title":"Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions","volume":"121","author":"Pedersen","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2023.10.019","article-title":"Differential regulation of wnt\/\u03b2-catenin signaling in acute and chronic epilepsy in repeated low dose lithium-pilocarpine rat model of status epilepticus","volume":"535","author":"Rawat","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.109931_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.584298","article-title":"Caloric restriction and ketogenic diet therapy for epilepsy: a molecular approach involving Wnt pathway and KATP channels","volume":"11","author":"Rubio","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1871527316666170117114513","article-title":"Increase signaling of Wnt\/\u03b2-catenin pathway and presence of apoptosis in cerebellum of kindled rats","volume":"16","author":"Rubio","year":"2017","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuropharm.2024.109931_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jep.2011.11.011","article-title":"Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression","volume":"139","author":"Singh","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11662-7","article-title":"6-bromo-indirubin-3\u2019-oxime (6BIO), a Glycogen synthase kinase-3\u03b2 inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts","volume":"7","author":"Sklirou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.109931_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/WNP.0b013e31826b3ab7","article-title":"Mesial temporal lobe epilepsy","volume":"29","author":"Tatum","year":"2012","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.109931_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074428","article-title":"Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis","volume":"8","author":"Theilhaber","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.109931_bib29","first-page":"559","article-title":"Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus","volume":"28","author":"Trinka","year":"2022","journal-title":"Continuum"},{"key":"10.1016\/j.neuropharm.2024.109931_bib30","article-title":"Utilizing the modified T-maze to assess functional memory outcomes after cardiac arrest","volume":"56694","author":"Wu","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2024.109931_bib31","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1242\/jcs.013771","article-title":"Mechanistic insights from structural studies of beta-catenin and its binding partners","volume":"120","author":"Xu","year":"2007","journal-title":"J. Cell Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T21:12:17Z","timestamp":1725484337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082400100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"alternative-id":["S002839082400100X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109931","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the effect of 6-BIO and sulindac in modulation of Wnt\/\u03b2-catenin signaling pathway in chronic phase of temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109931"}}